Validity and Reliability of Turkish Version of Bayer Activities of Daily Living Scale

NCT05449626 | Completed

• 1 other identifier: 2022/514/227/3
• Study Type: observational
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of our study is to verify the validity and reliability of the Turkish version of B-GYA.

Conditions

Alzheimer Disease; Activities of Daily Living

Keywords

Alzheimer's disease; Activities of Daily Living

Outcome Measures

Primary Outcomes (2)

• Standardized Mini Mental Test

  For the first time, Folstein et al. \[12\] and found to be valid and reliable in the diagnosis of mild dementia in the Turkish population will be used. SMMT, which measures mental state, is a scale that evaluates cognitive functions in five separate sections (orientation, registration, attention and calculation, recall and language). The test can be easily applied in daily medical practice and is very suitable for screening cognitive function in the elderly. The total score is 30. The cut-off point of the scale was determined as 24.

  Up to 6 months

• Clinical Dementia Rating Scale

  The Clinical Dementia Rating Scale was developed by Woolf in 2016 in order to have information about the participant's memory, orientation, judgment and problem-solving ability, functionality outside the home, home life, hobbies and personal care. An evaluation will be made by asking detailed questions about all the areas specified in this test, which will be applied to the patient and their relatives. According to the answers given in each field, it will be scored as 0-0.5-1-2-3 by using the score table in the front of the test. It is a general assessment made to determine the dementia stage of the person. 0.5-1 mild, 1-2 moderate, 2-3 advanced stages of dementia.

  Up to 6 months

Study Arms (2)

Alzheimer's disease group

Diagnostic Test: Assessment

Healthy Group

Diagnostic Test: Assessment

Interventions

Assessment DIAGNOSTIC_TEST

The Standardized Mini-Mental Test and Clinical Dementia Rating Scale will be administered by the physician to the healthy individuals with dementia to be included in the study.

Alzheimer's disease group; Healthy Group

Eligibility Criteria

• Age: 60 Years - 95 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

200 individuals and healthy individuals who were diagnosed with Alzheimer's according to the international diagnostic criteria of the American National Neurological and Communication Disorders Stroke and Alzheimer Association (NINCDS-ADRDA) and were in mild and moderate stages (\<2) according to the Clinical Dementia Rating: CDR. 200 individuals found will be included

You may qualify if:

• Individuals aged 60 and over
• Being literate
• Having given consent to participate in the study
• Individuals diagnosed with Alzheimer's according to the international diagnostic criteria of the American National Neurological and Communication Disorders Stroke and Alzheimer's Association (NINCDS-ADRDA) and in mild and moderate stages (\<2) according to the Clinical Dementia Rating: CDR will be included in the study.

You may not qualify if:

• Those who did not give consent to participate in the study
• CDR\>2
• Except for behavioral or functional symptoms associated with dementia, individuals with medical, psychiatric, neurological conditions, or physical disabilities that may significantly affect the performance of ADL will be excluded from the study.

Sponsors & Collaborators

• Yeditepe University: lead

Study Sites (1)

Yeditepe University

Istanbul, Turkiye, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Physical Examination

Condition Hierarchy (Ancestors)

Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and Procedures; Diagnosis

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 4, 2022
• First Posted: July 8, 2022
• Study Start: July 26, 2022
• Primary Completion: October 6, 2022
• Study Completion: January 6, 2023
• Last Updated: July 3, 2023

Record last verified: 2023-06

Locations

TU (1)